G-Protein β3-Subunit Gene C825T Polymorphism and Cardiovascular Risk: An Updated Review

High Blood Pressure and Cardiovascular Prevention

Volumn 22, Issue 3, 2015, Pages 225-232

  Semplicini, Andrea ^a,b   Grandi, Tommaso ^a   Sandonà, Chiara ^a   Cattelan, Arianna ^a   Ceolotto, Giulio ^a  

^a UNIVERSITY OF PADOVA   (Italy)

^b NONE   (Italy)

Author keywords

G proteins; GNB3 C825T; GNB3 gene; GNB3 polymorphism; Hypertension; Insulin resistance; Left ventricular hypertrophy; Obesity

Indexed keywords

ACETYLSALICYLIC ACID; CYSTEINE; G PROTEIN BETA 3 SUBUNIT; GUANINE NUCLEOTIDE BINDING PROTEIN; THREONINE; UNCLASSIFIED DRUG; GUANINE NUCLEOTIDE BINDING PROTEIN (G PROTEIN), BETA POLYPEPTIDE 3, HUMAN; HETEROTRIMERIC GUANINE NUCLEOTIDE BINDING PROTEIN;

ALLELE; AMINO ACID SUBSTITUTION; ARTICLE; CARDIOVASCULAR DISEASE; CARDIOVASCULAR MORTALITY; CARDIOVASCULAR RISK; CAUCASIAN; CEREBROVASCULAR ACCIDENT; CORONARY ARTERY DISEASE; DISEASE ASSOCIATION; ESSENTIAL HYPERTENSION; GENETIC MARKER; HEART INFARCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART LEFT VENTRICLE MASS; HUMAN; HYPERTENSION; INFLAMMATION; LIPID METABOLISM; LONGITUDINAL STUDY; META ANALYSIS; METABOLIC SYNDROME X; MORBIDITY; NONHUMAN; OBESITY; PRIORITY JOURNAL; RISK REDUCTION; SAMPLE SIZE; SINGLE NUCLEOTIDE POLYMORPHISM; ETHNOLOGY; GENETICS;

ALLELES; CORONARY ARTERY DISEASE; HETEROTRIMERIC GTP-BINDING PROTEINS; HUMANS; HYPERTENSION; HYPERTROPHY, LEFT VENTRICULAR; METABOLIC SYNDROME X; OBESITY; POLYMORPHISM, SINGLE NUCLEOTIDE; STROKE;

EID: 84941273617     PISSN: 11209879     EISSN: 11791985     Source Type: Journal    
DOI: 10.1007/s40292-015-0093-4     Document Type: Article

References (80)

1. Mancia G, Fagard R, Narkiewicz K, Redon J, Zanchetti A, Bohm M, Christiaens T, Cifkova R, De Backer G, Dominiczak A, Galderisi M, Grobbee DE, Jaarsma T, Kirchhof P, Kjeldsen SE, Laurent S, Manolis AJ, Nilsson PM, Ruilope LM, Schmieder RE, Sirnes PA, Sleight P, Viigimaa M, Waeber B, Zannad F, Task Force Members. ESH/ESC Guidelines for the management of arterial hypertension: the Task Force for the management of arterial hypertension of the European Society of Hypertension (ESH) and of the European Society of Cardiology (ESC). J Hypertens. 2013;2013(31):1281–357.
2. International Consortium for Blood Pressure Genome-Wide Association Studies, Ehret GB, Munroe PB, Rice KM, Bochud M, Johnson AD, Chasman DI, Smith AV, Tobin MD, Verwoert GC, Hwang SJ, Pihur V, Vollenweider P, O’Reilly PF, Amin N, Bragg-Gresham JL, Teumer A, Glazer NL, Launer L, Zhao JH, Aulchenko Y, Heath S, Sober S, Parsa A, Luan J, Arora P, Dehghan A, Zhang F, Lucas G, Hicks AA, Jackson AU, Peden JF, Tanaka T, Wild SH, Rudan I, Igl W, Milaneschi Y, Parker AN, Fava C, Chambers JC, Fox ER, Kumari M, Go MJ, van der Harst P, Kao WH, Sjogren M, Vinay DG, Alexander M, Tabara Y, Shaw-Hawkins S, Whincup PH, Liu Y, Shi G, Kuusisto J, Tayo B, Seielstad M, Sim X, Nguyen KD, Lehtimaki T, Matullo G, Wu Y, Gaunt TR, Onland-Moret NC, Cooper MN, Platou CG, Org E, Hardy R, Dahgam S, Palmen J, Vitart V, Braund PS, Kuznetsova T, Uiterwaal CS, Adeyemo A, Palmas W, Campbell H, Ludwig B, Tomaszewski M, Tzoulaki I, Palmer ND, CARDIoGRAM consortium, CKDGen Consortium, KidneyGen Consortium, EchoGen consortium, CHARGE-HF consortium, Aspelund T, Garcia M, Chang YP, O’Connell JR, Steinle NI, Grobbee DE, Arking DE, Kardia SL, Morrison AC, Hernandez D, Najjar S, McArdle WL, Hadley D, Brown MJ, Connell JM, Hingorani AD, Day IN, Lawlor DA, Beilby JP, Lawrence RW, Clarke R, Hopewell JC, Ongen H, Dreisbach AW, Li Y, Young JH, Bis JC, Kahonen M, Viikari J, Adair LS, Lee NR, Chen MH, Olden M, Pattaro C, Bolton JA, Kottgen A, Bergmann S, Mooser V, Chaturvedi N, Frayling TM, Islam M, Jafar TH, Erdmann J, Kulkarni SR, Bornstein SR, Grassler J, Groop L, Voight BF, Kettunen J, Howard P, Taylor A, Guarrera S, Ricceri F, Emilsson V, Plump A, Barroso I, Khaw KT, Weder AB, Hunt SC, Sun YV, Bergman RN, Collins FS, Bonnycastle LL, Scott LJ, Stringham HM, Peltonen L, Perola M, Vartiainen E, Brand SM, Staessen JA, Wang TJ, Burton PR, Soler Artigas M, Dong Y, Snieder H, Wang X, Zhu H, Lohman KK, Rudock ME, Heckbert SR, Smith NL, Wiggins KL, Doumatey A, Shriner D, Veldre G, Viigimaa M, Kinra S, Prabhakaran D, Tripathy V, Langefeld CD, Rosengren A, Thelle DS, Corsi AM, Singleton A, Forrester T, Hilton G, McKenzie CA, Salako T, Iwai N, Kita Y, Ogihara T, Ohkubo T, Okamura T, Ueshima H, Umemura S, Eyheramendy S, Meitinger T, Wichmann HE, Cho YS, Kim HL, Lee JY, Scott J, Sehmi JS, Zhang W, Hedblad B, Nilsson P, Smith GD, Wong A, Narisu N, Stancakova A, Raffel LJ, Yao J, Kathiresan S, O’Donnell CJ, Schwartz SM, Ikram MA, Longstreth WT,Jr, Mosley TH, Seshadri S, Shrine NR, Wain LV, Morken MA, Swift AJ, Laitinen J, Prokopenko I, Zitting P, Cooper JA, Humphries SE, Danesh J, Rasheed A, Goel A, Hamsten A, Watkins H, Bakker SJ, van Gilst WH, Janipalli CS, Mani KR, Yajnik CS, Hofman A, Mattace-Raso FU, Oostra BA, Demirkan A, Isaacs A, Rivadeneira F, Lakatta EG, Orru M, Scuteri A, Ala-Korpela M, Kangas AJ, Lyytikainen LP, Soininen P, Tukiainen T, Wurtz P, Ong RT, Dorr M, Kroemer HK, Volker U, Volzke H, Galan P, Hercberg S, Lathrop M, Zelenika D, Deloukas P, Mangino M, Spector TD, Zhai G, Meschia JF, Nalls MA, Sharma P, Terzic J, Kumar MV, Denniff M, Zukowska-Szczechowska E, Wagenknecht LE, Fowkes FG, Charchar FJ, Schwarz PE, Hayward C, Guo X, Rotimi C, Bots ML, Brand E, Samani NJ, Polasek O, Talmud PJ, Nyberg F, Kuh D, Laan M, Hveem K, Palmer LJ, van der Schouw YT, Casas JP, Mohlke KL, Vineis P, Raitakari O, Ganesh SK, Wong TY, Tai ES, Cooper RS, Laakso M, Rao DC, Harris TB, Morris RW, Dominiczak AF, Kivimaki M, Marmot MG, Miki T, Saleheen D, Chandak GR, Coresh J, Navis G, Salomaa V, Han BG, Zhu X, Kooner JS, Melander O, Ridker PM, Bandinelli S, Gyllensten UB, Wright AF, Wilson JF, Ferrucci L, Farrall M, Tuomilehto J, Pramstaller PP, Elosua R, Soranzo N, Sijbrands EJ, Altshuler D, Loos RJ, Shuldiner AR, Gieger C, Meneton P, Uitterlinden AG, Wareham NJ, Gudnason V, Rotter JI, Rettig R, Uda M, Strachan DP, Witteman JC, Hartikainen AL, Beckmann JS, Boerwinkle E, Vasan RS, Boehnke M, Larson MG, Jarvelin MR, Psaty BM, Abecasis GR, Chakravarti A, Elliott P, van Duijn CM, Newton-Cheh C, Levy D, Caulfield MJ, Johnson T. Genetic variants in novel pathways influence blood pressure and cardiovascular disease risk. Nature. 2011;478:103–9.
3. Siffert W, Rosskopf D, Siffert G, Busch S, Moritz A, Erbel R, Sharma AM, Ritz E, Wichmann HE, Jakobs KH, Horsthemke B. Association of a human G-protein beta3 subunit variant with hypertension. Nat Genet. 1998;18:45–8.
4. Cabrera-Vera TM, Vanhauwe J, Thomas TO, Medkova M, Preininger A, Mazzoni MR, Hamm HE. Insights into G protein structure, function, and regulation. Endocr Rev. 2003;24:765–81.
5. Virchow S, Ansorge N, Rubben H, Siffert G, Siffert W. Enhanced fMLP-stimulated chemotaxis in human neutrophils from individuals carrying the G protein beta3 subunit 825 T-allele. FEBS Lett. 1998;436:155–8.
6. Lindemann M, Virchow S, Ramann F, Barsegian V, Kreuzfelder E, Siffert W, Muller N, Grosse-Wilde H. The G protein beta3 subunit 825T allele is a genetic marker for enhanced T cell response. FEBS Lett. 2001;495:82–6.
7. Ryden M, Faulds G, Hoffstedt J, Wennlund A, Arner P. Effect of the (C825T) Gbeta(3) polymorphism on adrenoceptor-mediated lipolysis in human fat cells. Diabetes. 2002;51:1601–8.
8. Baumgart D, Naber C, Haude M, Oldenburg O, Erbel R, Heusch G, Siffert W. G protein beta3 subunit 825T allele and enhanced coronary vasoconstriction on alpha(2)-adrenoceptor activation. Circ Res. 1999;85:965–9.
9. Wenzel RR, Siffert W, Bruck H, Philipp T, Schafers RF. Enhanced vasoconstriction to endothelin-1, angiotensin II and noradrenaline in carriers of the GNB3 825T allele in the skin microcirculation. Pharmacogenetics. 2002;12:489–95.
10. Nurnberger J, Opazo Saez A, Mitchell A, Buhrmann S, Wenzel RR, Siffert W, Philipp T, Schafers RF. The T-allele of the C825T polymorphism is associated with higher arterial stiffness in young healthy males. J Hum Hypertens. 2004;18:267–71.
11. Siffert W, Forster P, Jockel KH, Mvere DA, Brinkmann B, Naber C, Crookes R, Du P Heyns A, Epplen JT, Fridey J, Freedman BI, Muller N, Stolke D, Sharma AM, Al Moutaery K, Grosse-Wilde H, Buerbaum B, Ehrlich T, Ahmad HR, Horsthemke B, Du Toit ED, Tiilikainen A, Ge J, Wang Y, Rosskopf D. Worldwide ethnic distribution of the G protein beta3 subunit 825T allele and its association with obesity in Caucasian, Chinese, and Black African individuals. J Am Soc Nephrol. 1999;10:1921–30.
12. Siffert W. G proteins and hypertension: an alternative candidate gene approach. Kidney Int. 1998;53:1466–70.
13. Semplicini A, Siffert W, Sartori M, Monari A, Naber C, Frigo G, Santonastaso M, Cozzutti E, Winnicki M, Palatini P. G protein beta3 subunit gene 825T allele is associated with increased left ventricular mass in young subjects with mild hypertension. Am J Hypertens. 2001;14:1191–5.
14. Wascher TC, Paulweber B, Malaimare L, Stadlmayr A, Iglseder B, Schmoelzer I, Renner W. Associations of a human G protein beta3 subunit dimorphism with insulin resistance and carotid atherosclerosis. Stroke. 2003;34:605–9.
15. Sartori M, Semplicini A, Siffert W, Mormino P, Mazzer A, Pegoraro F, Mos L, Winnicki M, Palatini P. G-protein beta3-subunit gene 825T allele and hypertension: a longitudinal study in young grade I hypertensives. Hypertension. 2003;42:909–14.
16. Sartori M, Parotto E, Pagnin E, Cattelan F, Ceolotto G, Papparella I, Lenzini L, Calò LA, Semplicini A. G-protein β3-subunit gene C825T Polymorphism and cardiovascular risk. High Blood Press Cardiovasc Prev. 2004;11:107–12.
17. Bagos PG, Elefsinioti AL, Nikolopoulos GK, Hamodrakas SJ. The GNB3 C825T polymorphism and essential hypertension: a meta-analysis of 34 studies including 14,094 cases and 17,760 controls. J Hypertens. 2007;25:487–500.
18. Niu W, Qi Y. Association of alpha-adducin and G-protein beta3 genetic polymorphisms with hypertension: a meta-analysis of Chinese populations. PLoS One. 2011;6:e17052.
19. Lu J, Guo Q, Zhang L, Wang W. Association between the G-protein beta3 subunit C825T polymorphism with essential hypertension: a meta-analysis in Han Chinese population. Mol Biol Rep. 2012;39:8937–44.
20. Zheng H, Xu H, Cui B, Xie N, Wang Z, Luo M. Association between polymorphism of the G-protein beta3 subunit C825T and essential hypertension: an updated meta-analysis involving 36,802 subjects. Biol Res. 2013;46:265–73.
21. Pereira TV, Kimura L, Suwazono Y, Nakagawa H, Daimon M, Oizumi T, Kayama T, Kato T, Li L, Chen S, Gu D, Renner W, Marz W, Yamada Y, Bagos PG, Mingroni-Netto RC. Multivariate meta-analysis of the association of G-protein beta 3 gene (GNB3) haplotypes with cardiovascular phenotypes. Mol Biol Rep. 2014;41:3113–25.
22. Franco V, Oparil S. Salt sensitivity, a determinant of blood pressure, cardiovascular disease and survival. J Am Coll Nutr. 2006;25:247S–55S.
23. Dong Y, Zhu H, Wang X, Dalageorgou C, Carter N, Spector TD, Snieder H. Obesity reveals an association between blood pressure and the G-protein beta3-subunit gene: a study of female dizygotic twins. Pharmacogenetics. 2004;14:419–27.
24. Kumar R, Kohli S, Alam P, Barkotoky R, Gupta M, Tyagi S, Jain SK, Pasha MA. Interactions between the FTO and GNB3 genes contribute to varied clinical phenotypes in hypertension. PLoS One. 2013;8:e63934.
25. Post WS, Larson MG, Myers RH, Galderisi M, Levy D. Heritability of left ventricular mass: the Framingham Heart Study. Hypertension. 1997;30:1025–8.
26. Poch E, Gonzalez D, Gomez-Angelats E, Enjuto M, Pare JC, Rivera F, de La Sierra A. G-Protein beta(3) subunit gene variant and left ventricular hypertrophy in essential hypertension. Hypertension. 2000;35:214–8.
27. Olszanecka A, Kawecka-Jaszcz K, Kuznetsova T, Stolarz K, Brand E, Ryabikov A, Herrmann SM, Nikitin Y, Staessen JA, European Project on Genes in Hypertension (EPOGH) Investigators. Ambulatory blood pressure and left ventricular structure and function in relation to the G-protein beta3-subunit polymorphism C825T in White Europeans. J Hum Hypertens. 2003;17:325–32.
28. Mahmood MS, Mian ZS, Afzal A, Frossard PM. G-protein beta-3 subunit gene 825C>T dimorphism is associated with left ventricular hypertrophy but not essential hypertension. Med Sci Monit. 2005;11:CR6–9.
29. Sedlacek K, Fischer M, Erdmann J, Hengstenberg C, Holmer S, Kurzinger S, Muscholl M, Luchner A, Riegger GA, Hense HW, Schunkert H. Relation of the G protein beta3-subunit polymorphism with left ventricle structure and function. Hypertension. 2002;40:162–7.
30. Shlyakhto EV, Shwartz EI, Nefedova YB, Zukova AV, Vinnic TA, Konrady AO. Lack of association of G-protein subunit gene C825T polymorphism with left ventricular hypertrophy in essential hypertension. Med Sci Monit. 2002;8:CR337–40.
31. Ukkola O, Bouchard C. Role of candidate genes in the responses to long-term overfeeding: review of findings. Obes Rev. 2004;5:3–12.
32. Moxham CM, Malbon CC. Insulin action impaired by deficiency of the G-protein subunit G ialpha2. Nature. 1996;379:840–4.
33. Chen JF, Guo JH, Moxham CM, Wang HY, Malbon CC. Conditional, tissue-specific expression of Q205L G alpha i2 in vivo mimics insulin action. J Mol Med (Berl). 1997;75:283–9.
34. Baritono E, Ceolotto G, Papparella I, Sartori M, Ciccariello L, Iori E, Calo L, Pessina AC, Semplicini A. Abnormal regulation of G protein alpha(i2) subunit in skin fibroblasts from insulin-resistant hypertensive individuals. J Hypertens. 2004;22:783–92.
35. Chang WT, Wang YC, Chen CC, Zhang SK, Liu CH, Chang FH, Hsu LS. The −308G/A of tumor necrosis factor (TNF)-alpha and 825C/T of guanidine nucleotide binding protein 3 (GNB3) are associated with the onset of acute myocardial infarction and obesity in Taiwan. Int J Mol Sci. 2012;13:1846–57.
36. Ko KD, Kim KK, Suh HS, Hwang IC. Associations between the GNB3 C825T polymorphism and obesity-related metabolic risk factors in Korean obese women. J Endocrinol Invest. 2014 [Epub ahead of print].
37. Maniotis C, Chantziara K, Kokkoris P, Papadogiannis D, Andreou C, Tsioufis C, Vaiopoulos G, Stefanadis C. The AGT and the GNB3 polymorphisms and insulin resistance in prehypertension. Hormones (Athens). 2014;13:79–86.
38. Hegele RA, Anderson C, Young TK, Connelly PW. G-protein beta3 subunit gene splice variant and body fat distribution in Nunavut Inuit. Genome Res. 1999;9:972–7.
39. Brand E, Wang JG, Herrmann SM, Staessen JA. An epidemiological study of blood pressure and metabolic phenotypes in relation to the Gbeta3 C825T polymorphism. J Hypertens. 2003;21:729–37.
40. Poston WS, Haddock CK, Spertus J, Catanese DM, Pavlik VN, Hyman DJ, Hanis CL, Forevt JP. Physical activity does not mitigate G-protein-related genetic risk for obesity in individuals of African descent. Eat Weight Disord. 2002;7:68–71.
41. Rankinen T, Rice T, Leon AS, Skinner JS, Wilmore JH, Rao DC, Bouchard C. G protein beta 3 polymorphism and hemodynamic and body composition phenotypes in the HERITAGE Family Study. Physiol Genomics. 2002;8:151–7.
42. Ohshiro Y, Ueda K, Wakasaki H, Takasu N, Nanjo K. Analysis of 825C/T polymorphism of G proteinbeta3 subunit in obese/diabetic Japanese. Biochem Biophys Res Commun. 2001;286:678–80.
43. Hinney A, Geller F, Neupert T, Sommerlad C, Gerber G, Gorg T, Siegfried W, Goldschmidt H, Remschmidt H, Ziegler A, Hebebrand J. No evidence for involvement of alleles of the 825-C/T polymorphism of the G-protein subunit beta 3 in body weight regulation. Exp Clin Endocrinol Diabetes. 2001;109:402–5.
44. Benjafield AV, Lin RC, Dalziel B, Gosby AK, Caterson ID, Morris BJ. G-protein beta3 subunit gene splice variant in obesity and overweight. Int J Obes Relat Metab Disord. 2001;25:777–80.
45. Hsiao TJ, Hwang Y, Liu CH, Chang HM, Lin E. Association of the C825T polymorphism in the GNB3 gene with obesity and metabolic phenotypes in a Taiwanese population. Genes Nutr. 2013;8:137–44.
46. Alberti KG, Eckel RH, Grundy SM, Zimmet PZ, Cleeman JI, Donato KA, Fruchart JC, James WP, Loria CM, Smith SC Jr, International Diabetes Federation Task Force on Epidemiology and Prevention, Hational Heart, Lung, and Blood Institute, American Heart Association, World Heart Federation, International Atherosclerosis Society, International Association for the Study of Obesity. Harmonizing the metabolic syndrome: a joint interim statement of the International Diabetes Federation Task Force on Epidemiology and Prevention; National Heart, Lung, and Blood Institute; American Heart Association; World Heart Federation; International Atherosclerosis Society; and International Association for the Study of Obesity. Circulation. 2009;120:1640–5.
47. Poch E, Giner V, Gonzalez-Nunez D, Coll E, Oriola J, de la Sierra A. Association of the G protein beta3 subunit T allele with insulin resistance in essential hypertension. Clin Exp Hypertens. 2002;24:345–53.
48. Yamamoto M, Abe M, Jin JJ, Wu Z, Tabara Y, Mogi M, Kohara K, Miki T, Nakura J. Association of GNB3 gene with pulse pressure and clustering of risk factors for cardiovascular disease in Japanese. Biochem Biophys Res Commun. 2004;316:744–8.
49. Pollex RL, Hanley AJ, Zinman B, Harris SB, Khan HM, Hegele RA. Metabolic syndrome in aboriginal Canadians: prevalence and genetic associations. Atherosclerosis. 2006;184:121–9.
50. Kiani JG, Saeed M, Parvez SH, Frossard PM. Association of G-protein beta-3 subunit gene (GNB3) T825 allele with Type II diabetes. Neuro Endocrinol Lett. 2005;26:87–8.
51. Fernandez-Real JM, Penarroja G, Richart C, Castro A, Vendrell J, Broch M, Lopez-Bermejo A, Ricart W. G protein beta3 gene variant, vascular function, and insulin sensitivity in type 2 diabetes. Hypertension. 2003;41:124–9.
52. Hayakawa T, Takamura T, Abe T, Kaneko S. Association of the C825T polymorphism of the G-protein beta3 subunit gene with hypertension, obesity, hyperlipidemia, insulin resistance, diabetes, diabetic complications, and diabetic therapies among Japanese. Metabolism. 2007;56:44–8.
53. Kato N, Sugiyama T, Morita H, Kurihara H, Yamori Y, Yazaki Y. G protein beta3 subunit variant and essential hypertension in Japanese. Hypertension. 1998;32:935–8.
54. von Beckerath N, Schusterschitz Y, Koch W, Griesser K, Mehilli J, Gorchakova O, Schomig A, Kastrati A. G protein beta 3 subunit 825T allele carriage and risk of coronary artery disease. Atherosclerosis. 2003;167:135–9.
55. Nurnberger J, Dammer S, Philipp T, Wenzel RR, Schafers RF. Metabolic and haemodynamic effects of oral glucose loading in young healthy men carrying the 825T-allele of the G protein beta3 subunit. Cardiovasc Diabetol. 2003;2:7.
56. Povel CM, Boer JM, Reiling E, Feskens EJ. Genetic variants and the metabolic syndrome: a systematic review. Obes Rev. 2011;12:952–67.
57. Kario K, Fujiwara M, Sone Y, Saiki K, Hoshide S, Shimada K, Schwartz JE, Matsuo M. G protein beta3 subunit gene variant, twenty-four-hour blood pressure, and hypertensive cerebrovascular disease in a Japanese population. Am J Hypertens. 1999;12:1159–60.
58. Brand E, Herrmann SM, Nicaud V, Ruidavets JB, Evans A, Arveiler D, Luc G, Plouin PF, Tiret L, Cambien F. The 825C/T polymorphism of the G-protein subunit beta3 is not related to hypertension. Hypertension. 1999;33:1175–8.
59. Naber CK, Husing J, Wolfhard U, Erbel R, Siffert W. Interaction of the ACE D allele and the GNB3 825T allele in myocardial infarction. Hypertension. 2000;36:986–9.
60. Hengstenberg C, Schunkert H, Mayer B, Doring A, Lowel H, Hense HW, Fischer M, Riegger GA, Holmer SR. Association between a polymorphism in the G protein beta3 subunit gene (GNB3) with arterial hypertension but not with myocardial infarction. Cardiovasc Res. 2001;49:820–7.
61. Morrison AC, Doris PA, Folsom AR, Nieto FJ, Boerwinkle E, Atherosclerosis Risk in Communities Study. G-protein beta3 subunit and alpha-adducin polymorphisms and risk of subclinical and clinical stroke. Stroke. 2001;32:822–9.
62. Yamada Y, Izawa H, Ichihara S, Takatsu F, Ishihara H, Hirayama H, Sone T, Tanaka M, Yokota M. Prediction of the risk of myocardial infarction from polymorphisms in candidate genes. N Engl J Med. 2002;347:1916–23.
63. Morrison AC, Bray MS, Folsom AR, Boerwinkle E. ADD1 460W allele associated with cardiovascular disease in hypertensive individuals. Hypertension. 2002;39:1053–7.
64. Tobin MD, Braund PS, Burton PR, Thompson JR, Steeds R, Channer K, Cheng S, Lindpaintner K, Samani NJ. Genotypes and haplotypes predisposing to myocardial infarction: a multilocus case-control study. Eur Heart J. 2004;25:459–67.
65. Klintschar M, Stiller D, Schwaiger P, Kleiber M. DNA polymorphisms in the tyrosine hydroxylase and GNB3 genes: association with unexpected death from acute myocardial infarction and increased heart weight. Forensic Sci Int. 2005;153:142–6.
66. Zhang L, Zhang H, Sun K, Song Y, Hui R, Huang X. The 825C/T polymorphism of G-protein beta3 subunit gene and risk of ischaemic stroke. J Hum Hypertens. 2005;19:709–14.
67. Nikitin AG, Chudakova DA, Spitsina EV, Minushkina LO, Zateishchikov DA, Nosikov VV, Debabov VG. Association of GNB3 gene C825T polymorphism with coronary heart disease. Genetika. 2007;43:1129–33.
68. Renner W, Hoffmann MM, Grunbacher G, Winkelmann BR, Boehm BO, Marz W. G-protein beta3 subunit (GNB3) gene polymorphisms and cardiovascular disease: the Ludwigshafen Risk and Cardiovascular Health (LURIC) study. Atherosclerosis. 2007;192:108–12.
69. Kostulas K, Brophy VH, Moraitis K, Manolescu A, Kostulas V, Gretarsdottir S, Cheng S, Hillert J. Genetic profile of ischemic cerebrovascular disease and carotid stenosis. Acta Neurol Scand. 2008;118:146–52.
70. Peters BJ, Maitland-van der Zee AH, Stricker BH, van Wieren-de Wijer DB, de Boer A, Kroon AA, de Leeuw PW, Schiffers P, Janssen RG, van Duijn CM, Klungel OH. Effectiveness of statins in the reduction of the risk of myocardial infarction is modified by the GNB3 C825T variant. Pharmacogenet Genomics. 2008;18:631–36.
71. Plat AW, Stoffers HE, Klungel OH, van Schayck CP, de Leeuw PW, Soomers FL, Schiffers PM, Kester AD, Kroon AA. The contribution of six polymorphisms to cardiovascular risk in a Dutch high-risk primary care population: the HIPPOCRATES project. J Hum Hypertens. 2009;23:659–67.
72. Holmen OL, Romundstad S, Melien O. Association between the G protein beta3 subunit C825T polymorphism and the occurrence of cardiovascular disease in hypertensives: the Nord-Trondelag Health Study (HUNT). Am J Hypertens. 2010;23:1121–7.
73. Zhang Y, Tian Y, Dong J, Li L, Dong Z, Deng X. Application of a multiplex SNP genotyping system in predicting genetic susceptibility to CAD in Chinese people of Han ethnicity. Med Sci Monit. 2010;16:BR384–95.
74. Voora D, Horton J, Shah SH, Shaw LK, Newby LK. Polymorphisms associated with in vitro aspirin resistance are not associated with clinical outcomes in patients with coronary artery disease who report regular aspirin use. Am Heart J. 2011;162(166–72):e1.
75. Casiglia E, Tikhonoff V, Boschetti G, Bascelli A, Saugo M, Guglielmi G, Caffi S, Rigoni G, Giordano N, Grasselli C, Martini B, Mazza A, De Lazzari F, Palatini P. The C825T GNB3 polymorphism, independent of blood pressure, predicts cerebrovascular risk at a population level. Am J Hypertens. 2012;25:451–7.
76. Daimon M, Sato H, Kaino W, Tada K, Takase K, Karasawa S, Wada K, Kameda W, Susa S, Oizumi T, Kayama T, Muramatsu M, Kato T. Association of the G-protein beta3 subunit gene polymorphism with the incidence of cardiovascular disease independent of hypertension: the Funagata study. J Hum Hypertens. 2013;27:612–6.
77. Guo L, Zhang LL, Zheng B, Liu Y, Cao XJ, Pi Y, Li BH, Li JC. The C825T polymorphism of the G-protein beta3 subunit gene and its association with hypertension and stroke: an updated meta-analysis. PLoS One. 2013;8:e65863.
78. Frey UH, Moebus S, Mohlenkamp S, Kalsch H, Bauer M, Lehmann N, Nothen M, Muhleisen TW, Stang A, Erbel R, Jockel KH, Peters J, Siffert W. GNB3 gene 825 TT variant predicts hard coronary events in the population-based Heinz Nixdorf Recall study. Atherosclerosis. 2014;237:437–42.
79. Martinez C, Anton AI, Bernal A, Lozano ML, Ferrer-Marin F, Corral J, Iniesta JA, Vicente V, Rivera J. Evaluation of novel platelet polymorphisms in stroke. Dichotomic effect of rs5443 in GNB3. J Clin Neurol. 2015;11:102–3.
80. CARDIoGRAMplusC4D Consortium, Deloukas P, Kanoni S, Willenborg C, Farrall M, Assimes TL, Thompson JR, Ingelsson E, Saleheen D, Erdmann J, Goldstein BA, Stirrups K, Konig IR, Cazier JB, Johansson A, Hall AS, Lee JY, Willer CJ, Chambers JC, Esko T, Folkersen L, Goel A, Grundberg E, Havulinna AS, Ho WK, Hopewell JC, Eriksson N, Kleber ME, Kristiansson K, Lundmark P, Lyytikainen LP, Rafelt S, Shungin D, Strawbridge RJ, Thorleifsson G, Tikkanen E, Van Zuydam N, Voight BF, Waite LL, Zhang W, Ziegler A, Absher D, Altshuler D, Balmforth AJ, Barroso I, Braund PS, Burgdorf C, Claudi-Boehm S, Cox D, Dimitriou M, Do R, DIAGRAM Consortium, CARDIOGENICS Consortium, Doney AS, El Mokhtari N, Eriksson P, Fischer K, Fontanillas P, Franco-Cereceda A, Gigante B, Groop L, Gustafsson S, Hager J, Hallmans G, Han BG, Hunt SE, Kang HM, Illig T, Kessler T, Knowles JW, Kolovou G, Kuusisto J, Langenberg C, Langford C, Leander K, Lokki ML, Lundmark A, McCarthy MI, Meisinger C, Melander O, Mihailov E, Maouche S, Morris AD, Muller-Nurasyid M, MuTHER Consortium, Nikus K, Peden JF, Rayner NW, Rasheed A, Rosinger S, Rubin D, Rumpf MP, Schafer A, Sivananthan M, Song C, Stewart AF, Tan ST, Thorgeirsson G, van der Schoot CE, Wagner PJ, Wellcome Trust Case Control Consortium, Wells GA, Wild PS, Yang TP, Amouyel P, Arveiler D, Basart H, Boehnke M, Boerwinkle E, Brambilla P, Cambien F, Cupples AL, de Faire U, Dehghan A, Diemert P, Epstein SE, Evans A, Ferrario MM, Ferrieres J, Gauguier D, Go AS, Goodall AH, Gudnason V, Hazen SL, Holm H, Iribarren C, Jang Y, Kahonen M, Kee F, Kim HS, Klopp N, Koenig W, Kratzer W, Kuulasmaa K, Laakso M, Laaksonen R, Lee JY, Lind L, Ouwehand WH, Parish S, Park JE, Pedersen NL, Peters A, Quertermous T, Rader DJ, Salomaa V, Schadt E, Shah SH, Sinisalo J, Stark K, Stefansson K, Tregouet DA, Virtamo J, Wallentin L, Wareham N, Zimmermann ME, Nieminen MS, Hengstenberg C, Sandhu MS, Pastinen T, Syvanen AC, Hovingh GK, Dedoussis G, Franks PW, Lehtimaki T, Metspalu A, Zalloua PA, Siegbahn A, Schreiber S, Ripatti S, Blankenberg SS, Perola M, Clarke R, Boehm BO, O’Donnell C, Reilly MP, Marz W, Collins R, Kathiresan S, Hamsten A, Kooner JS, Thorsteinsdottir U, Danesh J, Palmer CN, Roberts R, Watkins H, Schunkert H, Samani NJ. Large-scale association analysis identifies new risk loci for coronary artery disease. Nat Genet. 2013;45:25–33.